设研院(300732) - 2020 Q1 - 季度财报

Financial Performance - Total operating revenue for Q1 2020 was ¥237,631,252.23, a decrease of 7.28% compared to ¥256,300,759.72 in the same period last year[6] - Net profit attributable to shareholders was ¥36,285,474.47, down 22.15% from ¥46,612,210.58 year-on-year[6] - Basic and diluted earnings per share were both ¥0.190, representing a decrease of 44.12% from ¥0.340 in the same period last year[6] - Total operating costs for Q1 2020 were CNY 189,057,833.41, down 5.1% from CNY 199,174,007.65 in the same period last year[38] - The total profit for Q1 2020 was CNY 43,645,717.07, down 22.6% from CNY 56,378,333.68 in Q1 2019[40] - The company's operating profit for Q1 2020 was CNY 43,454,500.10, a decrease of 22.7% from CNY 56,295,331.59 in the previous year[40] - The net profit for Q1 2020 was CNY 36,818,402.45, down 21.2% from CNY 46,637,140.62 in the same period last year[40] - The total comprehensive income for Q1 2020 was CNY 36,818,402.45, down 21.2% from CNY 46,637,140.62 in the previous year[40] Cash Flow and Liquidity - Net cash flow from operating activities was -¥123,817,489.82, a decline of 210.24% compared to -¥39,910,570.39 in the previous year[6] - The cash flow from operating activities for Q1 2020 was negative CNY 123,817,489.82, compared to negative CNY 39,910,570.39 in the same period last year[48] - The ending balance of cash and cash equivalents was 268,684,648.48 yuan, down from 284,519,361.05 yuan in the previous period, reflecting liquidity pressure[53] - The company's cash and cash equivalents were CNY 444,917,305.33, down from CNY 543,495,613.37 at the end of 2019, representing a decrease of about 18.2%[29] - Cash inflow from investment activities totaled 265,830,206.77 yuan, significantly higher than 127,738,487.29 yuan in the previous period, reflecting increased investment recovery[51] - The net cash flow from investment activities was 29,892,062.98 yuan, a recovery from -256,524,000.01 yuan in the previous period, showing improved investment management[53] - The company is facing challenges in operational cash flow, with total cash outflows from operating activities reaching 235,380,298.91 yuan, up from 180,935,112.56 yuan in the previous period[51] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,027,017,411.54, down 2.60% from ¥4,134,516,829.70 at the end of the previous year[6] - The company's total assets as of March 31, 2020, amounted to CNY 3,287,439,985.22, a decline from CNY 3,417,463,008.09 at the end of 2019[34] - Total liabilities decreased to CNY 1,147,499,333.88 in Q1 2020 from CNY 1,285,938,074.19 in Q4 2019, indicating a reduction of 10.7%[35] - The total liabilities were 1,358,736,604.71 yuan, maintaining a manageable level relative to total assets[56] - Total current assets amounted to 3,149,903,372.47 yuan, indicating a stable asset base despite cash flow challenges[56] - The company's total non-current assets were CNY 981,915,481.73, slightly down from CNY 984,613,457.23, indicating a decrease of approximately 0.3%[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,734[10] - The largest shareholder, Henan Jiaoyuan Investment Holding Co., Ltd., held 32.67% of the shares, totaling 62,694,558 shares[10] - The total amount of repurchased shares reached 3,179,150, accounting for 1.66% of the total share capital, with a total expenditure of approximately RMB 52.07 million as of March 31, 2020[16] - The company plans to repurchase shares with a total fund not exceeding RMB 100 million, estimating to buy around 4.55 million shares, which is about 2.37% of the total issued shares[16] Investment and Projects - The cumulative amount of raised funds is RMB 688.72 million, with RMB 5.44 million invested in the current quarter[19] - The total amount of raised funds that has been utilized is RMB 514.22 million, representing 74.6% of the total raised funds[19] - The project to enhance production capacity has seen an investment of RMB 16.76 million, achieving 88.88% of the planned investment[20] - The project to enhance management capability has received RMB 4.90 million, reaching 34.87% of the planned investment[20] - The project to enhance research and development capability has only achieved 19.06% of the planned investment, with RMB 2.92 million utilized[20] - The company has adjusted the implementation schedule for the enhancement of management and research capabilities projects to December 31, 2021, due to delays caused by government regulations and the COVID-19 pandemic[20] Research and Development - The company is focusing on research and development, with R&D expenses amounting to CNY 14,289,524.87, down from CNY 16,726,209.49 in the previous year, indicating a potential shift in investment strategy[38] - Research and development expenses for Q1 2020 were CNY 8,609,518.00, down 16.0% from CNY 10,257,571.73 in the previous year[43] Regulatory and Compliance - The company will implement the new revenue recognition standards starting January 1, 2020, affecting the cumulative impact on retained earnings[58] - The first quarter report was not audited, indicating that the figures may be subject to change[64]